baber/WOPTO huggingface dataset:
Patent FI-863151-A0 (FI)
Inventor: SHIH YEN-JER
IPC: C08F2/32
Filed: 1986-08-01
Abstract: Polysaccharide graft copolymers are prepared by a water-in-oil emulsion polymerization process in which the polysaccharide and water-soluble monomer are emulsified in an oil phase containing emulsifying agents and polymerized therein. The resultant emulsion polymers are in stable form and may be used directly, for example, as adhesives for prepasted wallpaper, or may be inverted into aqueous systems and used for their thickening or flocculating properties.
Patent FI-871607-A0 (FI)
Inventor: MURAKAMI KENJI
IPC: C12R1/91
Filed: 1987-04-13
Abstract: A method of producing desired peptides by transforming mammalian cells and cultivating the transformed cells can be improved by using myeloma cells as the mammalian cells and/or using a vector having the SV40 early promoter sequence on both the 5' upstream and 3' downstream sides of the gene coding for the desired peptide.
Patent FI-875289-A0 (FI)
Inventor: PRIESS MICHAEL
IPC: C07D471/04
Filed: 1987-12-01
Abstract: A process for the preparation of quinolinecarboxylic acids of the formula (I) <IMAGE> in which R<1>, R<2> and R<3>, X and A have the meaning given in the description, which are used as such or in the form of their esters, salts, prodrugs etc. as antibacterial agents in human and veterinary medicine and as agents stimulating the immune defence.
Patent FI-884822-A0 (FI)
Inventor: METRAUX MICHEL
IPC: B60C27/06
Filed: 1988-10-19
Abstract: This device is designed to be automatically placed in position by stressing and holding members (50) which move the device from a fitted position to the working position where the antislip assembly (70) is arranged on the peripheral surface of the tyre (10). It possesses a primary annular part (30) attached rigidly to the antislip assembly (70), for example by arms (40), and so designed that the holding member (50) can be fixed to this annular part (30) and move freely around the latter's circumference. 
<IMAGE>
Patent FI-885425-A0 (FI)
Inventor: LIE TORE
IPC: A47C1/032
Filed: 1988-11-23
Abstract: Adjustable chair, whereby the seat of the chair comprising on each side a rail (10) secured to a front portion under the seat (3) and resting on a pulley (11) connected with the chair frame, the seat being, in the rear portion on each side, connected turnably with a guide (5) secured to the frame where the guide having slideably arranged a first glider (6), the back (4) comprising a downwards and forwards directed prolongation and being turnably connected with the first glider (6), the front end of the prolongation being turnably connected with a second glider (8) being slideably arranged on a second guide (7), the second guide thereby being connected with the frame, and first and second guides (5, 7) being arranged in an obtuse angle in relation to each other such that the distance between the rear portion of seat and the lower portion of the back substantially is maintained whereas the angle between the seat and the back is altered when the back is moved backwards by the user in such a way that the gliders (5, 7) and the seat (3) are displaced forwards.
Patent FI-890105-A0 (FI)
Inventor: KUENZLER PETER
IPC: A63C11/08
Filed: 1989-01-09
Abstract: The device allows a method to be carried out to treat the sliding surfaces of winter sports devices. The latter are retained with their sliding surface towards the top. Their treatment takes place by means of a heatable plate with a porous insert which can be placed resiliently against the sliding surface and is displaceable relative to the latter in the longitudinal direction. From a trough, the insert can receive a material which can be heated at least to a pasty state. A storage device for porous sheet material dispenses said material, when required, between the sole and the sliding surface. The treatment can comprise: the removal of remains of used agent from the sliding surface, which agent is absorbed by the sheet material, and/or the pre-heating of the sliding surface, the sole sliding over the sliding surface without sheet material, and/or the application of new agent from the trough, the sheet material allowing fine distribution. In this case, the agent penetrates into microcavities of the covering and any cracks in the sliding surfaces and forms a smooth, even and elastic layer on the sliding surface. 
<IMAGE>
Patent FI-891896-A0 (FI)
Inventor: SPICKETT ROBERT GEOFFREY WILLI
IPC: A61K33/08
Filed: 1989-04-20
Abstract: Antacid powders, tablets etc. of prolonged gastric residence time have an internal phase of a solid antacid and excipient surrounded by a solid external phase containing a hydrophobic substance e.g. an ester of glycerol with palmitic or stearic acid, a hydroxylated polyalkene and a non-ionic emulsifier.
Patent FI-902335-A0 (FI)
Inventor: MYLARI BANAVARA LAKSHMANA
IPC: C12N9/99
Filed: 1990-05-10
Abstract: A series of novel 6-substituted-5-oxo-6H-pyrido[2,3-d]pyridazine-8-ylacetic acid and 7-substituted-8-oxo-7H-pyrido[2,3-d]pyridazine-5-ylacetic acid compounds have been prepared, including their C1-C6 alkyl ester derivatives, as well as the base salts of said acids with pharmacologically acceptable cations. Typical member compounds include those acids wherein the ring substituent is always attached to the available ring-nitrogen atom and is either a lower aralkyl group or a lower heteroaralkyl group. These compounds are useful in therapy as aldose reductase inhibitors for the control of certain chronic diabetic complications. Methods for preparing these compounds from known starting materials are provided.
Patent FI-922058-A0 (FI)
Inventor: TAKAHASHI SHUJI C O SANKYO COM
IPC: A61K39/40
Filed: 1992-05-06
Abstract: The present invention relates to a novel antibacterial compound of formula (I) from the genus Alteromonas and which shares structural similarity with the pseudomonic acids. <CHEM> i
Patent FI-922099-A0 (FI)
Inventor: BARE THOMAS MICHAEL ICI AMERIC
IPC: A61P25/00
Filed: 1992-05-08
Abstract: Compsn. for treating neurological disorders contains, apart from a diluent or carrier, a pyridazino-quinoline cpd. of formula (I) or its pharmaceutically acceptable salt. R3 = H, NH2, NHNH2, OH or SH; A = (Ia) (any one C atom not involved in the ring junction can be replaced by N); R4-R7 = H, halo, 1-4C alkyl (opt. contg. double or triple bond), 1-3C perfluoroalkyl or 1-3C alkyl substd. by CF3, NO2, ORd, COORd, CON(Rd)2, CN, N(Rd)2 or cyclopropyl; each Rd is H or 1-4C alkyl. Included are cpds. obtd. from (I) by mono-, di- or tri-acylation with R8COX' or by mono-, di- or tri-alkylation with R12X, and their pharmaceutically acceptable salts. X and X' = conventional leaving gp.; R8 = H, 1-12C alkyl (opt. contg. a double or triple bond and opt. substd. by CN, ORe, COORe, N(Rf)2 or CON(Rf)2); N(Rg)2; pyridyl, pyridyl(1-12C)alkyl; phenyl or phenyl(1-4C)alkyl opt. ring-substd. by 0-3 of halo, NH2, OH, CN, NO2 or 1-4C alkyl or alkoxy; Re = H, 1-4C alkyl, phenyl or phenyl(1-4C)alkyl (opt. ring-substd. as above); Rf = Rh, CORh or COORh in N(Rf)2 or Rh is CON(Rf)2; Rh is as Re or 2 together complete a satd. 4-7 membered ring; Rg are as Rh; R12 = 1-4C alkyl (opt. contg. a double or triple bond in which case a CH2 must be present between the multiple bond and the gp. to give R12 is attached); phenyl(1-4C)alkyl (opt. ring-substd. as above) or (CH2)mCOORa; Ra = H or 1-4C alkyl; m = 1-6.
Patent FI-934319-A0 (FI)
Inventor: TENGESDAL PAUL
IPC: F16K1/54
Filed: 1993-10-01
Abstract: PCT No. PCT/NO92/00051 Sec. 371 Date Sep. 24, 1993 Sec. 102(e) Date Sep. 24, 1993 PCT Filed Mar. 27, 1992 PCT Pub. No. WO92/17721 PCT Pub. Date Oct. 15, 1992.A valve for a pipe system wherein liquid circulates is intended to be controlled dependent on the liquid temperature within the system by means of a thermostat adapted to actuate an electro magnet which, on its part, dependent on whether it is current-carrying or not, is adapted to retain the valve spindle in a position corresponding to open or closed valve position, respectively. The valve housing has plate-shaped seat body having a large central through-going flow opening and a number of smaller corresponding openings closer to the circumference. A spring-loaded first valve body is displaceably arranged on the spindle and cooperates with the central opening of the seat body in order to close/open the opening, a concentrical, spring-loaded hollow piece constituting a second valve body which also is displaceably arranged on the spindle cooperating with the peripheric openings via an annular flange portion in order to close/open the last-mentioned openings. The two valve bodies are axially displaceable in relation to each other, and they are each assigned a carrier on the spindle.
Patent FI-940437-A0 (FI)
Inventor: LANGLEY JOHN GRAHAM
IPC: C02F11/123
Filed: 1994-01-28
Abstract: A suspension which is preferably an ink-containing waste suspension recovered from a paper deinking process is flocculated by a cationic polymeric flocculant, and the flocculated material is then aggregated by an anionic colloidal material mixed into the flocculated suspension, optionally further cationic flocculant is added, and the aggregated material is then separated from the suspension by belt press or other pressure filtration.
Patent FI-940513-A0 (FI)
Inventor: KOHONEN RAIMO
IPC: D21D5/06
Filed: 1994-02-04
Abstract: The present invention relates to a method of treating recycled fiber pulp by washing impurities like ash, ink and stickies therefrom. The method is characterized by the steps of spraying the recycled pulp onto a filter surface, removing impurities through the filter surface with the filtrate, allowing a web to be formed on the filter surface, breaking the web, allowing the web to be reformed by removing impurities and filtrate through the filter surface, and discharging the treated recycled pulp from the apparatus. It is typical of the apparatus in accordance with the present invention that at least one means (16) is provided for supplying recycled pulp onto a filter surface, said means being arranged above a horizontal plane passing along the axis of the cylinder (10).
Patent FI-941650-A0 (FI)
Inventor: DAUBIE CHRISTOPHE
IPC: C07C205/44
Filed: 1994-04-08
Abstract: New fluoro-3-quinolinecarboxylic acid derivatives of general formula (I), in which R is a hydrogen atom or an alkyl radical and Hal is a halogen atom, and its salts where such exist, their preparation and their use as synthetic intermediates. <IMAGE>
Patent FI-945258-A0 (FI)
Inventor: DION DOMINIQUE
IPC: F42B12/62
Filed: 1994-11-08
Abstract: PCT No. PCT/FR94/00104 Sec. 371 Date Oct. 24, 1994 Sec. 102(e) Date Oct. 24, 1994 PCT Filed Jan. 28, 1994 PCT Pub. No. WO94/20817 PCT Pub. Date Sep. 15, 1994.A wedging device includes bars evenly distributed at an angle. Each bar has a bearing surface designed to come into contact with an internal surface of the envelope and two holding surfaces designed to come into contact with at least two adjacent sub-munitions. Each bar is divided into at least two half-bars that contact one another by at least one slanted guiding surface. By relative sliding of each half-bar, the two holding surfaces forced apart in such a way as to eliminate any radial give in the sub-munition assembly within the envelope.
Patent FI-950091-A0 (FI)
Inventor: MENCKE NORBERT
IPC: A61K38/08
Filed: 1995-01-09
Abstract: Endoparasitic activity of cyclic depsipeptides (I) comprising amino acid and hydroxycarboxylic acid units and having 6-30 ring atoms is increased by praziquantel (II) and epsiprantel (III). An endoparasitic agent contg. (I) together with (II) and (III) is also claimed. Known cpds. (I) are disclosed in EP382173 (depsipeptide PF 1022), WO9319053, J. Antibiotics 45 (1992) pp. 1207-1255 and pp 1273-1277, Helv. Chimn. Acta 46 (1963) pp 927-935 and pp 1715-1720, ibid, 47 (1964) pp. 166-173, Tetrahedron Letters 2 (1971) pp. 159-162, Biochem. Biophys. Res. Commun. 57 (1974) pp. 554-561 and Zh. Obshch. Khim. 41-(10) (10972) pp. 2320-2334. (II) is known from GB1441554 and (II) is known from EP134984 and EP185012.
Patent FI-950774-A0 (FI)
Inventor: LIPP RALPH
IPC: A61K9/70
Filed: 1995-02-20
Abstract: A transdermal application agent is characterized in that it contains 3-keto-desogestrel, if required combined with one or two estrogens.
Patent FI-953613-A0 (FI)
Inventor: LUHTALA JARMO
IPC: C05C9/02
Filed: 1995-07-28
Abstract: An oligomethylene urea product usable as a fertilizer can be more efficiently prepared in several steps by:a) introducing at least urea and an aqueous solution of formaldehyde in the overall molar ratio of urea to formaldehyde of the step 1:1-2:1 into a reactor with a retention time of at least 0.5 h, a temperature maintained in the range of 40 to 95° C. and a pH maintained in the range of 6.5 to 11, in order to produce a methylol urea composition,b) conducting the methylol urea composition to a second reactor with a temperature maintained in the range of 5 to 35° C. and a pH maintained in the range of 1.8 to 3.5, in order to produce a first oligomethylene urea slurry, and optionally,c) conducting the methylol urea composition or the first oligomethylene urea slurry to a third reactor with a temperature maintained in the range of 5 to 35° C. and a pH maintained in the range of 1.8 to 3.5, to produce a second oligomethylene urea slurry,d) conducting the oligomethylene urea slurry, selected from the first and the second oligomethylene urea slurry, to a filter and filtering it to form an oligomethylene urea precipitate and a filtrate,e) recycling the filtrate to the reactor, selected from the second and the third reactor, andf) neutralizing and drying the oligomethylene precipitate and recovering it as said oligomethylene urea product.
Patent FI-960452-A0 (FI)
Inventor: ONNEWEER FREDERIK J
IPC: B65D85/32
Filed: 1996-01-31
Abstract: An egg storer (10) includes a relatvely rigid transparent outer box (12) formed of two hinged shells (18, 20) and receiving a pair of removable cushioning inserts (14, 16). Each insert (14, 16) includes pockets (74) therein which receive and cushion eggs, and suspend the eggs above the bottom wall of the box. The pockets (74) are arranged in two rows of spaced pockets with the rows longitudinally offset and the pockets of adjacent rows generally transversely internested. The overall configuration of the box and internal inserts is an elongate and narrow oblique parallelepiped. <IMAGE>
Patent FI-963648-A0 (FI)
Inventor: EAGLES WARREN PAUL
IPC: C09D17/00
Filed: 1996-09-16
Abstract: PCT No. PCT/GB95/00563 Sec. 371 Date Nov. 21, 1996 Sec. 102(e) Date Nov. 21, 1996 PCT Filed Mar. 16, 1995 PCT Pub. No. WO95/25146 PCT Pub. Date Sep. 21, 1995A process for improving the rheological properties of an aqueous suspension of a particulate inorganic material which comprises the steps of: (a) forming an aqueous suspension of the particulate inorganic material and an effective amount of an anionic polyelectrolyte dispersing agent; (b) diluting the suspension formed in step (a) with water while maintaining the particulate in the dispersed state of step (a) to give a solids concentration of not less than 20% by weight of the particulate inorganic material; and (c) reconcentrating the diluted suspension formed in step (b) to give a solids concentration of at least 50% by weight of the particulate inorganic material.
Patent FI-964250-A0 (FI)
Inventor: TOURNIER HERVE
IPC: A61K49/00
Filed: 1996-10-22
Abstract: The present invention concerns injectable blood pool contrast agents for NMR and X-ray imaging purpose. These blood pool agents carry imaging contrast enhancers, e.g. paramagnetic or, respectively, radio-opaque compounds for imaging the circulation and/or circulation targeted organs. The blood pool agent compositions are formulated to protect the contrast agents from early removable by the reticulo-endothelial (RES) system of the liver and the spleen, so that they stay in the circulation long enough to provide good images of the blood vessels and blood perfused organs. X-ray and NMR imaging of the circulation and of targeted organs can strongly assist in diagnosing possible ailments in human and animal patients.
Patent FI-981756-A0 (FI)
Inventor: HOLOPAINEN KARI
IPC: D21G1/00
Filed: 1998-08-14
Abstract: A method for changing the natural frequency of a nip roll construction in a paper or board machine. In the method, the bearing elasticity of a hydrostatic bearing element (10, 20, 30, 40) of at least one roll (1) in the nip roll construction is changed, in which connect the natural frequency of the roll (1) is also changed. The device that carries out the method comprises a pressure medium accumulator (39), which has been connected to the pressure side of a loading element (13, 23, 33) of at least one hydrostatic bearing element (10, 20, 30).
Patent IL-60007-A0 (IL)
Title: 1-phenyl-2-aminoethanol derivatives
IPC: A61K31/22
Filed: 1980-05-06
Abstract: The invention concerns compounds of the formula:- R1.CH(OH).CH2NH.CR2R3.A1. NH.CO.CHR4.A2.NR5. Q I wherein R1 is 3,4-bis[(3-8C)alkanoyloxy]-phenyl, 3,5- bis [(3-8C)alkanoyloxy]phenyl, 3-[(3-8C)alkanoyloxy]methyl-4-[(3-8C)alkanoyloxy]phenyl, 4-[(3-8C)alkanoyloxy]phenyl, 2-chlorophenyl or 3,5-dichloro-4-aminophenyl; R2 and R3 are independently hydrogen or (1-4C) alkyl; A1 is (1-4C) alklylene; A2 is a direct bond or (1-4C) alkylene; R4 is hydrogen, (1-6C)alkyl, phenyl-(1-4C)alkyl or halogenophenyl-(1-4 C)alkyl; and R5 is (1-6C)alkyl; or R4 and R5 together form (2-5C) alkylene; and Q is (3-12C) alkanoyl, [(3-6C)alkoxy]carbonyl, phenylacetyl, phenoxyacetyl, benzoyl or benzyloxycarbonyl, the phenyl rings of which may optionally bear a substitutent selected from halogeno, (1-4C)alkyl, (1-4C)alkoxy and trifuloromethyl; and the pharmaceutically acceptable acid-addition salts thereof; processes for their manufacture; and pharmaceutical compositions thereof. The compounds of formula I are topical anti-inflammatory agents. A representative compound is 1-[3,4-bis (pivaloyloxy)phenyl]-2-{2-[(N-phenylacetyl-proyly)amino]-1,1-dimethyl- ethylamino}ethanol.
Patent IL-61214-A0 (IL)
Title: Electrode coated with platinum-group metal catalyst and semi-conducting polymer and its manufacture
IPC: C25B11/04
Filed: 1980-10-06
Abstract: A catalytic electrode has an electrically conductive substrate such as titanium with a coating comprising a platinum-group metal catalyst finely dispersed in a matrix consisting of a semi-conducting polymer formed in situ on the substrate. The catalyst may be a platinum-group metal oxide such as iridium oxide formed in situ together with the semi-conducting polymer by the application of a uniform liquid mixture followed by a controlled heat treatment. 
<??>The semi-conducting polymer is preferably formed from polyacrylonitrile, polybenzimidazo-pyrrolone or an adamantane based polybenzoxazole.
Patent IL-62930-A0 (IL)
Title: Electrochromic display device with improved erasing charcteristic
IPC: G02F1/1524
Filed: 1981-05-21
Abstract: An electrochromic device having an electrochromic layer of persistent electrochromic material such as tungsten oxide, and an electrolyte layer and a counter electrode which comprises an oxidizing agent which has oxidizing electrode potential more negative than the electrochromic layer to provide a stored charge for erasing color from the electrochromic layer, and to increase the emf of the charge used for the erase function. Examples of suitable oxidizing agents are manganese dioxide and chromic oxide.
Patent IL-66987-A0 (IL)
Title: Benzoquinoline derivatives,their preparation and pharmaceutical compositions containing them
IPC: C07C69/738
Filed: 1982-10-14
Abstract: A 6- and/or 7-oxy-trans-1,2,3,4,4a,5,10,10a-octahydro- benzo[g]-quinoline in which the 3-position is substituted by an optionally amidated carboxy group, an optionally etherified hydroxymethyl group, a cyanomethyl group, an alkyl-or aryl-thiomethyl group or a sulfamoylamino or carbamoylamino group, or a physiologically-hydrolysable and -acceptable ester thereof. The subject compounds are useful as pharmaceuticals, in particular as prolactin secretion inhibitors, dopaminergic agents and dopamine receptor stimulating agents.
Patent IL-70107-A0 (IL)
Title: Preparation of 2,3-dihydro-2,2-dimethyl-7-hydroxybenzofuran
IPC: C07D307/86
Filed: 1983-11-01
Abstract: For the Contracting States : AT, BE, CH, GB, LI, LU, NL, SE 1. A process for the preparation of 2,3-dihydro-2,2-dimethyl-7-hydroxybenzofuran from ortho-methallyloxyphenol by heating, by rearrangement or the ortho-methallyloxyphenol and then cyclisation of the rearranged compound thus obtained, wherein at least the cyclisation step is carried out by heating in the presence of an effective amount of a catalyst consisting of a tin derivative. For the Contracting States : DE, FR, IT 1. A process for the preparation of 2,3-dihydro-2,2-dimethyl-7-hydroxybenzofuran from ortho-methallyloxyphenol by heating, by rearrangement or the ortho-methallyloxyphenol and then cyclisation of the rearranged compound thus obtained, wherein at least the cyclisation step is carried out by heating in the presence of an effective amount of a catalyst consisting of a tin derivative which is not SnCI4 .
Patent IL-72491-A0 (IL)
Title: Aminopyrimidinone derivatives,pharmaceutical compositions containing them,their use as histamine h2-antagonists,processes for their preparation and intermediates therefor
IPC: C07D401/12
Filed: 1984-07-25
Abstract: Compounds of the formula (I): <CHEM> and their salts are histamine H2-antagonists, wherein: R<0> is 2-guanidinothiazol-4-yl or a group R<1>R<2>N(CH2)nZ- wherein R<1> and R<2> are hydrogen or various substituted alkyl groups or are joined together to form a ring; n ist 1 to 6; Z is 2,5-furanyl, 2,5-thienyl, 2,4-pyridyl (wherein R<1>R<2>N(CH2)n- is at position 4), 2,4-thiazolyl (wherein R<1>R<2>N(CH2)n is at position 2) or 1,3-or 1,4-phenylene; m is zero or one; Y is a bond, oxygen, sulphur or methylene; p is 2 to 4; q is zero or one; R<3> is hydrogen or C1-6 @alkyl@; and R<4> is hydrogen or C1-6alkanoyl. Pharmaceutical compositions containing them are described as are processes for their preparation and intermediates therefor.
Patent IL-76577-A0 (IL)
Title: 2-pyridine-thiol derivatives,their preparation and pharmaceutical compositions containing them
IPC: A61K31/4402
Filed: 1985-10-04
Abstract: The invention relates to new 2-pyridine-thiol derivatives of the formula (I),    <IMAGE>  (I)  wherein R is hydrogen or alkyl having from 1 to 4 carbon atoms, Z is phenyl optionally substituted by one or more halogen atoms and/or alkyl groups having from 1 to 4 carbon atoms, R1 and R2 each independently represents hydrogen, alkyl having from 1 to 4 carbon atoms, alkylphenyl having from 1 to 4 carbon atoms in the alkyl moiety or an   <IMAGE>   group, in which R has the same meaning as defined above, and the substituent   <IMAGE>   is attached to the pyridine ring in the position 3 or 4, with the proviso that if R1 and R2 are both methyl and Z is 4-chlorophenyl, R is other than hydrogen, and acid addition salts thereof. The invention further relates to processes for the preparation of the above compounds and to pharmaceutical compositions containing them as active ingredient. The compounds are pharmaceutically active, in particular show cytoprotective activity.
Patent IL-86603-A0 (IL)
Title: Oxazolidin-2-one derivatives as hypoglycemic agents
IPC: C07D417/14
Filed: 1988-06-02
Abstract: Oxazolidin-2-one derivs. of formula (I), corresp. pharmaceutically-acceptable acid addn. salt or pharmaceutically-acceptable cationic salt are new. Rb is (i), (ii) (iii) or (iv), W is S or O; X, X' is H, Cl, F or CF3; Y is -COOR1, -CON(R1)CH2CONR3R3, gp. (v) or vi), Ra, R1, R2, R3 are H, CH3, R4 is CH3 or CF3. For pharmaceutically-acceptable acid addn. salt, Y is gp. (v) or Rb is gp. (iii). For pharmaceutically-acceptable cationic salt y is -COOH or gp. (vi). - Also claimed is an optically active cpd. of formula (I) and use of cpd. (I) as a medicament for the treatment of hyperglycemia.